Comments
Loading...
Schott Pharma Analyst Ratings and Price Targets | OTC:SHTPY | Benzinga
Schott Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Schott Pharma Corp from these most-recent analyst ratings.
Analyst Ratings for Schott Pharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Schott Pharma (SHTPY) stock?
There is no price target for Schott Pharma
What is the most recent analyst rating for Schott Pharma (SHTPY)?
There is no analyst for Schott Pharma
When was the last upgrade for Schott Pharma (SHTPY)?
There is no last upgrade for Schott Pharma
When was the last downgrade for Schott Pharma (SHTPY)?
There is no last downgrade for Schott Pharma.
When is the next analyst rating going to be posted or updated for Schott Pharma (SHTPY)?
There is no next analyst rating for Schott Pharma.
Is the Analyst Rating Schott Pharma (SHTPY) correct?
There is no next analyst rating for Schott Pharma.
Browse analyst ratings and price targets on all stocks.